Article
GDF15 and ACE2 stratify COVID-19 patients according to severity while ACE2 mutations increase infection susceptibility.
Frontiers in cellular and infection microbiology - 1 Jan 2022
Torrens-Mas Margalida, Perelló-Reus Catalina M, Trias-Ferrer Neus, Ibargüen-González Lesly, Crespí Catalina, Galmes-Panades Aina Maria, Navas-Enamorado Cayetano, Sanchez-Polo Andres, Piérola-Lopetegui Javier, Masmiquel Luis, Crespi Lorenzo Socias, Barcelo Carles, Gonzalez-Freire Marta
Abstract excerpt
Coronavirus disease 19 (COVID-19) is a persistent global pandemic with a very heterogeneous disease presentation ranging from a mild disease to dismal prognosis. Early detection of sensitivity and severity of COVID-19 is essential for the development of new treatments. In the present study, we measured the levels of circulating growth differentiation factor 15 (GDF15) and angiotensin-converting enzyme 2 (ACE2) in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
